X

 

We would like to inform you that Viatris, the marketing authorisation holder for Creon® has decided to increase the capsule length of Creon® 25000 from 21.7mm to 24.2mm. The diameter of the capsule will not change.

The new size of Creon® 25000 capsule does not affect the efficacy of the product and should not have an impact on the patient’s ability to swallow the capsules whole.

Viatris Connect
Keywords..

Resources

Viatris Connect is an online platform for UK healthcare professionals.

AIM:

Our aim with Viatris Connect is to ensure you are fully informed and up to date on all of our products and therapy areas.

Loading the player...
CREATE ACCOUNT

ABOUT:

  • Across Viatris Connect you will find news, blogs, product information and webinars sharing knowledge and experience.
  • All of our patient support information is easily available to order and download at any time.
  • Please note that the website contains promotional and non-promotional material including educational content and resources to help you and your patients prescribed Creon®.

REGISTER NOW

For your practice

For your patients

You are leaving the Creon® healthcare professional website

You are now connecting to a website that is neither owned nor under the control of Viatris. Viatris is not responsible for the content of this site or any further links.
Please press OK to proceed or BACK to return to the Creon® healthcare professional website.
BACK
OK

You will now leave the Creon patient website and go to the Creon Track site where you can join the Creon Track patient support programme

Would you like to proceed to the Creon Track registration website?

OK
NO
Please continue to report suspected adverse drug reactions and device failures with any medicine or vaccine to the MHRA through the Yellow Card Scheme. It is easiest and quickest to report adverse drug reactions and device failures online via the Yellow Card website: https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Alternatively, you can report via some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) or by calling the Commission on Human Medicines (CHM) free phone line: 0800-731-6789.
Adverse reactions/events and device failures should also be reported to MAH at e-mail address: pv.uk@viatris.com.

This website is intended for UK healthcare professionals. If you are a patient who has been prescribed Creon® please click here

Viatris UK Healthcare Limited (company registration number 09189103), an English company with a registered office address at 20 Station Close, Potters Bar, Hertfordshire, EN6 1TL (VAT - 421 623 781).

Creon® is indicated for the treatment of pancreatic exocrine insufficiency.

CRE-2021-0769 December 2023.

This website is owned and managed by Viatris. 

Copyright © 2023 Viatris Inc. All rights reserved.